Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNF | P01375 | 1/20 | 0.35 |
| ▸ | LITAF | Q99732 | 1/20 | 0.35 |
| ▸ | HPD | P32754 | 2/20 | 0.33 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.32 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyanide SCHEMBL25408005 | 0.91 | PDE4B (0.33) | PTGER4PDE4BALDH1A1 | |
| Cyanide SCHEMBL25406203 | 0.86 | ADORA2B (0.39) | HPDPDE4BALDH1A1 | |
| Cyanide SCHEMBL25439614 | 0.85 | PTGER4 (0.32) | PTGER4PDE4B | |
| Cyanide SCHEMBL25406280 | 0.82 | HSD17B10 (0.38) | HPD | |
| Cyanide SCHEMBL25406456 | 0.81 | HPD (0.46) | HPDALDH1A1 | |
| Cyanide SCHEMBL25406638 | 0.79 | PDE4B (0.34) | TNFLITAFPDE4B | |
| SCHEMBL30349743 | 0.77 | ALDH1A1 (0.44) | TNFLITAFHPDPTGER4PDE4B | |
| SCHEMBL25408308 | 0.77 | ALDH1A1 (0.44) | TNFLITAFHPDPTGER4PDE4B | |
| Cyanide SCHEMBL25404661 | 0.76 | HSD17B10 (0.37) | — | |
| Cyanide SCHEMBL25405734 | 0.75 | ALDH1A1 (0.39) | HPDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230295095-A1 | NOVEL FUSED-HETEROCYCLYL-CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS AND USE THEREOF | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2023-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230295095-A1 | NOVEL FUSED-HETEROCYCLYL-CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS AND USE THEREOF | CBR3, DBF4, DDT | TNF 4793/4885LITAF 2991/4885HPD 888/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.